AxoGen, Inc.AXGNNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
|
|
|
|

Year-over-year research & development expense growth

Latest
1.57%
↓ 94% below average
Average (9y)
27.20%
Historical baseline
Range
High:75.74%
Low:1.57%
CAGR
-14.9%
Structural decline
PeriodValue
20241.57%
20236.68%
20226.00%
202135.48%
20201.90%
201948.76%
201875.74%
201759.05%
201630.11%
20156.72%